Overview

Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)

Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
A Double-Blind Placebo-Controlled Random Order Crossover Pilot Study of Iloperidone for Symptoms of Arousal in PTSD.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
Novartis Pharmaceuticals
Treatments:
Iloperidone